ES2033755T3 - Nueva combinacion sinergica consistente en un inhibidor de fosfodiesterasa y un antagonista de tronboxano-a2 y su empleo y preparacion. - Google Patents

Nueva combinacion sinergica consistente en un inhibidor de fosfodiesterasa y un antagonista de tronboxano-a2 y su empleo y preparacion.

Info

Publication number
ES2033755T3
ES2033755T3 ES198787112773T ES87112773T ES2033755T3 ES 2033755 T3 ES2033755 T3 ES 2033755T3 ES 198787112773 T ES198787112773 T ES 198787112773T ES 87112773 T ES87112773 T ES 87112773T ES 2033755 T3 ES2033755 T3 ES 2033755T3
Authority
ES
Spain
Prior art keywords
antagonist
new
thronboxan
preparation
phosphodiesterase inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787112773T
Other languages
English (en)
Inventor
Walter Dr. Haarmann
Josef Dr. Dipl.-Chem. Nickl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Application granted granted Critical
Publication of ES2033755T3 publication Critical patent/ES2033755T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

OBJETO DE LA PRESENTE INVENCION ES LA NUEVA COMBINACION SINERGICA, CONSISTENTE EN UN INHIBIDOR PDE Y UN ANTAGONISTA DE TROMBOXANO A2 Y SUS UTILIZACIONES PARA LA PROFILAXIS Y EL TRATAMIENTO DE LAS TROMBOSIS VENOSAS Y ARTERIALES, ASI COMO UN PROCEDIMIENTO PARA SU OBTENCION.
ES198787112773T 1986-09-13 1987-09-02 Nueva combinacion sinergica consistente en un inhibidor de fosfodiesterasa y un antagonista de tronboxano-a2 y su empleo y preparacion. Expired - Lifetime ES2033755T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863631294 DE3631294A1 (de) 1986-09-13 1986-09-13 Neue synergistische kombination bestehend aus einem phosphodiesterase-hemmer und einem thromboxan-a(pfeil abwaerts)2(pfeil abwaerts)-antagonisten und deren verwendung bzw. herstellung

Publications (1)

Publication Number Publication Date
ES2033755T3 true ES2033755T3 (es) 1993-04-01

Family

ID=6309586

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787112773T Expired - Lifetime ES2033755T3 (es) 1986-09-13 1987-09-02 Nueva combinacion sinergica consistente en un inhibidor de fosfodiesterasa y un antagonista de tronboxano-a2 y su empleo y preparacion.

Country Status (12)

Country Link
EP (1) EP0260527B1 (es)
JP (1) JPS6379838A (es)
KR (1) KR880003624A (es)
AU (1) AU597718B2 (es)
DE (2) DE3631294A1 (es)
DK (1) DK472487A (es)
ES (1) ES2033755T3 (es)
GR (1) GR3004969T3 (es)
IL (1) IL83872A0 (es)
NZ (1) NZ221779A (es)
PH (1) PH23553A (es)
ZA (1) ZA876806B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306846A3 (de) * 1987-09-11 1990-05-02 Dr. Karl Thomae GmbH Neue synergistische Kombination bestehend aus einem Phosphodiesterase-Hemmer und einem Thromboxan-A2-Antagonisten und deren Verwendung bzw. Herstellung
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
JP2003509478A (ja) 1999-09-21 2003-03-11 エモリー・ユニバーシティ 血小板関連障害を処置する方法および組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291368A (en) * 1979-03-30 1981-09-22 Borg-Warner Corporation Pulse-width modulated inverter system and method
EP0054132B1 (de) * 1980-12-12 1984-10-10 Dr. Karl Thomae GmbH Neue Pyrimidinone, ihre Herstellung und Arzneimittel mit einem Gehalt an diesen Stoffen
DE3049207A1 (de) * 1980-12-27 1982-07-29 Dr. Karl Thomae Gmbh, 7950 Biberach Neue trisubstituierte pyrimido (5,4-d) pyrimidine, ihre herstellung und ihre verwendung als arzneimittel
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor

Also Published As

Publication number Publication date
JPS6379838A (ja) 1988-04-09
PH23553A (en) 1989-08-25
EP0260527A3 (en) 1989-08-09
DK472487A (da) 1988-03-14
AU597718B2 (en) 1990-06-07
DK472487D0 (da) 1987-09-10
NZ221779A (en) 1990-03-27
EP0260527A2 (de) 1988-03-23
AU7829687A (en) 1988-03-17
DE3631294A1 (de) 1988-03-24
EP0260527B1 (de) 1992-04-01
IL83872A0 (en) 1988-02-29
KR880003624A (ko) 1988-05-28
GR3004969T3 (es) 1993-04-28
ZA876806B (en) 1989-05-30
DE3777926D1 (de) 1992-05-07

Similar Documents

Publication Publication Date Title
ES2097782T3 (es) Metodo y composicion para la determinacion de iones sodio en fluidos.
MX9204111A (es) Triazoles substituidos y procedimiento para su obtencion.
SV2003001173A (es) 1-alquil o 1-cicloalquil-triazolo [4,3-a] quinazolin-5- onas como inhibidoras de fosfodiesterasa
SE7804325L (sv) Sett for framstellning av oljehaltiga, hogrenade fosfatidylkoliner
PT869946E (pt) Fenilimidazolidinas e sua utilizacao como agentes anti-androgenicos
ES2026669T3 (es) Procedimiento para la preparacion y el uso terapeutico de los beta-d-fenil tioxilosidos.
ES2157992T3 (es) Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas.
DE3887151D1 (de) Inhibitoren für zellenzuwachs und methoden für krebsbehandlung.
FI895447A0 (fi) Substituerade adeninderivat anvaendbara som terapeutiska substanser.
NO932377D0 (no) Antivirale forbindelser
ES2033755T3 (es) Nueva combinacion sinergica consistente en un inhibidor de fosfodiesterasa y un antagonista de tronboxano-a2 y su empleo y preparacion.
ES2080311T3 (es) Nuevos derivados de escualeno de ciclopropilo y su utilizacion como inhibidor de sintesis del colesterol.
IT7819135A0 (it) Impiego di difenileteri come algicidi.
IT7827927A0 (it) Procedimento per la cementazione agas di utensili di acciaio.
ZA874123B (en) Variants of alpha1-antitrypsin which are useful,in particular,as kallikrein inhibitors
FR2383185A1 (es)
ES2066927T3 (es) Procedimiento para la purificacion de polialquileneterglicoles, que contienen heteropoliacidos.
ES2051954T3 (es) 2-aminotiazoles substituidos.
ES2063224T3 (es) Benzoxacinil-pirazoles, su produccion y su uso.
ES2166838T3 (es) 6-(triazolil(3-(trifluorometil)fenil)metil)-2-quinolinonas y -quinolinationas.
MX9401172A (es) Derivados fluorados de 4-aminoandrostadienona, procesamiento para su preparacion y composiciones farmaceuticas que los contienen.
IT1056193B (it) Procedimento per la cromatura galvanica con l impiego di agenti bagnanti contenenti fluoro
ES2056310T3 (es) Aditivo para baño y su empleo.
FR2372784A1 (fr) Derives aldehydiques de cyclopentane utiles comme agents odoriferants
ES2039290T3 (es) Procedimiento para preparar nuevos esteres aralquilicos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 260527

Country of ref document: ES